MyAverix Finance
F · Healthcare
Knight Therapeutics Inc (04K)
Drug Manufacturers - Specialty & Generic
Knight Therapeutics Inc (04K) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $510.53M, P/E ratio is 130.00, net margin is 1.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 04K
Knight Therapeutics Inc (04K) — FAQ
What is Knight Therapeutics Inc's market cap?
Knight Therapeutics Inc (04K) has a reported market cap of $510.53M (data as of 2026-05-24).
What is 04K's P/E ratio?
The price-to-earnings (P/E) ratio for Knight Therapeutics Inc (04K) is 130.00 (data as of 2026-05-24).
Does Knight Therapeutics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Knight Therapeutics Inc (04K). Check the MyAverix Finance app for the latest dividend data.
What sector is Knight Therapeutics Inc in?
Knight Therapeutics Inc (04K) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 04K listed on?
04K is listed on F.
What is Knight Therapeutics Inc's net margin?
Knight Therapeutics Inc (04K) reports a net margin of 1.1% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.